Illumina Inc ILMN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:10 PM EDT
209.06UNCH (UNCH)
Volume
23,023
Close
209.06quote price arrow down-3.96 (-1.86%)
Volume
998,969
52 week range
173.45 - 524.99
Loading...
  • Open213.00
  • Day High213.55
  • Day Low207.10
  • Prev Close213.02
  • 52 Week High524.99
  • 52 Week High Date08/18/21
  • 52 Week Low173.45
  • 52 Week Low Date07/14/22

Key Stats

  • Market Cap32.843B
  • Shares Out157.10M
  • 10 Day Average Volume2.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change-45.05

KEY STATS

  • Open213.00
  • Day High213.55
  • Day Low207.10
  • Prev Close213.02
  • 52 Week High524.99
  • 52 Week High Date08/18/21
  • 52 Week Low173.45
  • 52 Week Low Date07/14/22
  • Market Cap32.843B
  • Shares Out157.10M
  • 10 Day Average Volume2.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change-45.05

RATIOS/PROFITABILITY

  • EPS (TTM)-0.08
  • P/E (TTM)-2,565.15
  • Fwd P/E (NTM)72.74
  • EBITDA (TTM)49.00M
  • ROE (TTM)-0.26%
  • Revenue (TTM)4.692B
  • Gross Margin (TTM)67.54%
  • Net Margin (TTM)-0.43%
  • Debt To Equity (MRQ)16.66%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO8:2908:29
Friday, August 12, 2022: Why this sector is strong on falling oil prices

Profile

MORE
Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems...
John Thompson
Independent Chairman of the Board
Francis deSouza
President, Chief Executive Officer, Director
Alex Aravanis M.D., Ph.D.
Chief Technology Officer, Head of Research and Product Development
Carissa Rollins
Chief Information Officer
Charles Dadswell
General Counsel, Secretary
Address
5200 Illumina Way
San Diego, CA
92122-4616
United States

Top Peers

SYMBOLLASTCHG%CHG
ALNY
Alnylam Pharmaceuticals Inc
223.45+0.32+0.14%
GMAB
Genmab A/S
35.93-0.34-0.94%
BIIB
Biogen Inc
216.34-1.24-0.57%
INCY
Incyte Corp
73.62-0.24-0.32%
CRL
Charles River Laboratories International Inc
220.15+0.10+0.05%